Everything you need to make the right decisions
Providing the most comprehensive and up-to-date information and analysis of the OTC Analgesics and Cold and Flu Remedies market, its consumers and the major players who make up that market.
Point of sale market data
In conjunction with IRi, extensive point of sale data shows you what consumers are spending their money on
How big is the market today and what is our 5 year forecast? Includes both best & worst case scenarios
What are the different segments within the market and how are those individual segments performing?
What are consumers looking for, what drives their buying habits and what are their main purchase influencers?
From iGen & Millennials to Baby Boomers & beyond. Who is spending money and what are they spending it on?
We gather our data from real-world consumers, selected to accurately reflect precise global demographics
What are the key players doing, what has been successful for them and what was their marketing spend?
Using data from our Global New Product Database, what products were launched and how well were they perceived?
What happens next, which areas are likely to experience growth and what opportunities exist within the market?
Expert analysis from a specialist in the field
Written by Hera Crossan, a leading analyst in the Health sector, her extensive knowledge delivers in-depth commentary and analysis to highlight current trends and add expert context to the numbers.
The British population is facing a health crisis – it is getting older, more overweight and a growing culture of ‘presenteeism’ is resulting in many employees placing additional stress and strain on their bodies when rest and recuperation is what’s needed. The OTC analgesics and cold and flu remedies market has been well placed to benefit from growing pressure on the NHS, however, increasing confidence in own-label products threatens to undermine value growth.
Mintel has the answers you’re looking for
What are the key challenges facing the industry and how fast are its rates of growth? Who is the consumer and what do they want? Where are the opportunities, where are the risks and what lies ahead?
This report discusses the following key topics:
Products covered in this Report
This Report covers only OTC, non-prescription medication,
defined by the Proprietary Association of Great Britain as being:
‘Specifically designed to treat the symptoms of common, minor
and self-limiting ailments that do not require a medical diagnosis.’
They are divided into two categories:
- P: Pharmacy-only products, which can only be sold through
pharmacies by or in the presence of a qualified pharmacist
- GSL: General Sales List, which can be sold in any type of
This Report examines the UK consumer market for OTC
analgesics (also referred to as OTC painkillers and OTC pain
remedies throughout this Report). The OTC analgesics market
is defined as including all analgesics available over the counter
without a prescription. This includes topical analgesics (pain relief
gels, creams and sprays), alongside oral analgesics, oral lesions
and toothache remedies.
This Report also covers the UK consumer market for OTC
cold and flu remedies, cough remedies and decongestants,
- Cold remedies: for the treatment of colds, including capsules,
tablets, syrups and liquid, powders, hot drinks, caplets and
- Decongestants: for the relief of stuffy, blocked up nasal
passages, available as embrocation or rub nasal inhalants and
- Flu remedies: for the treatment of flu, including capsules,
tablets, syrups and liquids, powders, hot drinks, caplets and
- Cough remedies: for the relief of coughing, available as syrups
- Medicated confectionery: for the relief of sore throats, nasal
congestion and coughing